Location History:
- Cambridge, GB (2017 - 2018)
- Cambridgeshire, GB (2017 - 2020)
Company Filing History:
7 out of 17 
3 out of 69 
1 out of 259 
Years Active: 2017-2020
Title: An Insight into the Innovations of Bruno Flavio Nogueira De Sousa Soares
Introduction
Bruno Flavio Nogueira De Sousa Soares is a prominent inventor based in Cambridgeshire, GB. He holds an impressive portfolio of 7 patents that showcase his expertise and contributions to the field of microfluidics and nucleotide sequencing.
Latest Patents
Among his latest inventions is the microfluidic device for characterizing polynucleotides. This device operates by utilizing a stream of microdroplets, some of which contain single nucleotide bases. The reaction with a capture system allows for the detection of an ordered sequence of single nucleotide bases produced by progressive pyrophosphorolysis. Another noteworthy patent encompasses a single nucleotide detection method. This innovative method determines the sequence of nucleotide bases in a polynucleotide analyte through a series of steps: generating a stream of single nucleotide bases via pyrophosphorolysis, producing captured molecules, releasing detectable elements from these molecules, and finally, detecting these elements to ascertain the nucleotide sequence. This method demonstrates significant advantages for sequencers utilizing microdroplets.
Career Highlights
Bruno has made substantial strides in his career, having worked for noteworthy companies such as Base4 Innovation Limited and United Kingdom Research and Innovation. His contributions to these organizations have advanced the field of biotechnology and microfluidic research.
Collaborations
During his career, Bruno has collaborated with talented individuals such as Cameron Alexander Frayling and Barnaby Balmforth. These collaborations have fostered innovative ideas and further strengthened their collective impact in the industry.
Conclusion
Through his innovative patents and significant collaborations, Bruno Flavio Nogueira De Sousa Soares has established himself as a key figure in his field. His work, particularly in microfluidic technologies and nucleotide sequencing, continues to pave the way for future advancements in biotechnology.